A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control

Diabetologia

Volumn 58, Issue 8, 2015, Pages 1855-1867

  Yousri, Noha A ^a,b   Mook Kanamori, Dennis O ^a,c   Selim, Mohammed M El Din ^d   Takiddin, Ahmed H ^d   Al Homsi, Hala ^d   Al Mahmoud, Khoulood A S ^d   Karoly, Edward D ^e   Krumsiek, Jan ^f   Do, Kieu Thinh ^f   Neumaier, Ulrich ^f   Mook Kanamori, Marjonneke J ^a   Rowe, Jillian ^a   Chidiac, Omar M ^a   McKeon, Cindy ^a   Al Muftah, Wadha A ^a   Kader, Sara Abdul ^a   Kastenmüller, Gabi ^f,g   Suhre, Karsten ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^b Alexandria University The Faculty Of Engineering   (Egypt)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d HAMAD MEDICAL CORPORATION   (Qatar)

^e METABOLON INC   (United States)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

^g GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

Arab population; Asian population; Blood metabolomics; Gaussian graphical modelling; Glycaemic control; Metabolic dysregulation; Partial correlation; Saliva metabolomics; Systems biology; Type 2 diabetes; Urine metabolomics

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GLYCEMIC CONTROL; GLYCOLYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; KETONURIA; MAJOR CLINICAL STUDY; MALE; METABOLITE; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PLASMA; PRIORITY JOURNAL; SALIVA; URINE; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; METABOLOMICS; MIDDLE AGED; SALIVA; YOUNG ADULT;

EID: 84937518347     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3636-2     Document Type: Article

References (60)

1. Nicholson JK, Lindon JC, Holmes E (1999) ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181–1189
2. Pauling L, Robinson AB, Teranishi R, Cary P (1971) Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A 68:2374–2376
3. Suhre K (2014) Metabolic profiling in diabetes. J Endocrinol 221:R75–R85
4. Menni C, Fauman E, Erte I et al (2013) Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes 62:4270–4276
5. Suhre K, Meisinger C, Doring A et al (2010) Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One 5, e13953
6. Fiehn O, Garvey WT, Newman JW, Lok KH, Hoppel CL, Adams SH (2010) Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One 5, e15234
7. Wang C, Kong H, Guan Y et al (2005) Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. Anal Chem 77:4108–4116
8. Floegel A, Stefan N, Yu Z et al (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62:639–648
9. Newgard CB, An J, Bain JR et al (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311–326
10. Wang TJ, Larson MG, Vasan RS et al (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17:448–453
11. Gall WE, Beebe K, Lawton KA et al (2010) Alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One 5:e10883
12. Wang TJ, Ngo D, Psychogios N et al (2013) 2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest 123:4309–4317
13. Mook-Kanamori DO, El-Din Selim MM, Takiddin AH et al (2014) 1,5-Anhydroglucitol in saliva is a non-invasive marker of short-term glycemic control. J Clin Endocrinol Metab 99:E479–483
14. McGill JB, Cole TG, Nowatzke W et al (2004) Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay. Diabetes Care 27:1859–1865
15. Krumsiek J, Suhre K, Illig T, Adamski J, Theis FJ (2011) Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data. BMC Syst Biol 5:21
16. Krumsiek J, Suhre K, Evans AM et al (2012) Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information. PLoS Genet 8, e1003005
17. Shin S-Y, Fauman EB, Petersen A-K et al (2014) An atlas of genetic influences on human blood metabolites. Nat Genet 46:543–550
18. Altmaier E, Emeny RT, Krumsiek J et al (2013) Metabolomic profiles in individuals with negative affectivity and social inhibition: a population-based study of type D personality. Psychoneuroendocrinology 38:1299–1309
19. Ried JS, Baurecht H, Stückler F et al (2013) Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma. Allergy 68:629–636
20. Do KT, Kastenmuller G, Mook-Kanamori DO et al (2014) Network-based approach for analyzing intra-and interfluid metabolite associations in human blood, urine, and saliva. J Proteome Res 14:1183–1194
21. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E (2009) Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 81:6656–6667
22. Dehaven CD, Evans AM, Dai H, Lawton KA (2010) Organization of GC/MS and LC/MS metabolomics data into chemical libraries. J Cheminform 2:9
23. Gilliland IC, Martin MM (1951) Raised blood pyruvic acid level in diabetic acidosis; the value of cocarboxylase in treatment. Br Med J 1:14–16
24. Messana I, Forni F, Ferrari F, Rossi C, Giardina B, Zuppi C (1998) Proton nuclear magnetic resonance spectral profiles of urine in type II diabetic patients. Clin Chem 44:1529–1534
25. Adams SH (2011) Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutr Res (Bethesda, MD) 2:445–456
26. Bingham C, Ellard S, Nicholls AJ et al (2001) The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1alpha mutations is a feature of all patients with diabetes and is associated with glucosuria. Diabetes 50:2047–2052
27. Landaas S (1975) Accumulation of 3-hydroxyisobutyric acid, 2-methyl-3-hydroxybutyric acid and 3-hydroxyisovaleric acid in ketoacidosis. Clin Chim Acta Int J Clin Chem 64:143–154
28. Patterson AD, Bonzo JA, Li F et al (2011) Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus. J Biol Chem 286:19511–19522
29. Cook DG, Shaper AG, Thelle DS, Whitehead TP (1986) Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 62:1001–1006
30. Herman JB, Goldbourt U (1982) Uric acid and diabetes: observations in a population study. Lancet 2:240–243
31. Tuomilehto J, Zimmet P, Wolf E, Taylor R, Ram P, King H (1988) Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji. Am J Epidemiol 127:321–336
32. Whitehead TP, Jungner I, Robinson D, Kolar W, Pearl A, Hale A (1992) Serum urate, serum glucose and diabetes. Ann Clin Biochem 29(Pt 2):159–161
33. Ferrannini E, Natali A, Camastra S et al (2013) Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes 62:1730–1737
34. Cobb J, Gall W, Adam KP et al (2013) A novel fasting blood test for insulin resistance and prediabetes. J Diabetes Sci Technol 7:100–110
35. Wurtz P, Soininen P, Kangas AJ et al (2013) Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care 36:648–655
36. Williamson DH, Ellington EV (1975) Hydroxypyruvate as a gluconeogenic substrate in rat hepatocytes. Biochem J 146:277–279
37. Goldstein DS, Eisenhofer G, Kopin IJ (2003) Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther 305:800–811
38. Aung MH, Park HN, Han MK et al (2014) Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes. J Neurosci Off J Soc Neurosci 34:726–736
39. Faresjo T, Faresjo A (2010) To match or not to match in epidemiological studies–same outcome but less power. Int J Environ Res Public Health 7:325–332
40. de Graaf MA, Jager KJ, Zoccali C, Dekker FW (2011) Matching, an appealing method to avoid confounding? Nephron Clin Pract 118:c315–c318
41. Lu J, Zhou J, Bao Y et al (2012) Serum metabolic signatures of fulminant type 1 diabetes. J Proteome Res 11:4705–4711
42. Wijekoon EP, Brosnan ME, Brosnan JT (2007) Homocysteine metabolism in diabetes. Biochem Soc Trans 35:1175–1179
43. Szabo A, Kenesei E, Korner A, Miltenyi M, Szucs L, Nagy I (1991) Changes in plasma and urinary amino acid levels during diabetic ketoacidosis in children. Diabetes Res Clin Pract 12:91–97
44. Tuma P, Samcova E, Balinova P (2005) Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Anal Technol Biomed Life Sci 821:53–59
45. Zhou Y, Qiu L, Xiao Q et al (2013) Obesity and diabetes related plasma amino acid alterations. Clin Biochem 46:1447–1452
46. Eremina IA, Mamaeva GG, Likhacheva NV, Burobin VA (1986) Urocanic acid content of the epidermis of diabetics. Probl Endokrinol (Mosk.) 32:15–18
47. Zhang AH, Sun H, Yan GL, Yuan Y, Han Y, Wang XJ (2014) Metabolomics study of type 2 diabetes using ultra-performance LC-ESI/quadrupole-TOF high-definition MS coupled with pattern recognition methods. J Physiol Biochem 70:117–128
48. Olmos JM, Garcia MT, Amado JA, Gonzalez-Macias J (1996) Urine hydroxyproline increase in patients with diabetes mellitus. Diabet Med J Br Diabet Assoc 13:284
49. Zhao Y, Fu L, Li R et al (2012) Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med 10:153
50. Avogaro A, Bier DM (1989) Contribution of 3-hydroxyisobutyrate to the measurement of 3-hydroxybutyrate in human plasma: comparison of enzymatic and gas-liquid chromatography-mass spectrometry assays in normal and in diabetic subjects. J Lipid Res 30:1811–1817
51. Liebich HM, Forst C (1984) Hydroxycarboxylic and oxocarboxylic acids in urine: products from branched-chain amino acid degradation and from ketogenesis. J Chromatogr 309:225–242
52. Schooneman MG, Vaz FM, Houten SM, Soeters MR (2013) Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes 62:1–8
53. Patel SG, Hsu JW, Jahoor F et al (2013) Pathogenesis of A(-)beta(+) ketosis-prone diabetes. Diabetes 62:912–922
54. Yamanouchi T, Ogata N, Tagaya T et al (1996) Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet 347:1514–1518
55. Scheijen JL, Hanssen NM, van de Waarenburg MP, Jonkers DM, Stehouwer CD, Schalkwijk CG (2012) L(+) and D(-) lactate are increased in plasma and urine samples of type 2 diabetes as measured by a simultaneous quantification of L(+) and D(-) lactate by reversed-phase liquid chromatography tandem mass spectrometry. Exp Diabetes Res 2012:234812
56. Busch M, Franke S, Muller A et al (2004) Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. Kidney Int 66:338–347
57. Trevisan R, Nosadini R, Avogaro A et al (1986) Type I diabetes is characterized by insulin resistance not only with regard to glucose, but also to lipid and amino acid metabolism. J Clin Endocrinol Metab 62:1155–1162
58. Sheikh-Ali M, Karon BS, Basu A et al (2008) Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care 31:643–647
59. Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ (1984) Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem 30:426–432
60. Brennan L, Corless M, Hewage C et al (2003) 13C NMR analysis reveals a link between L-glutamine metabolism, D-glucose metabolism and gamma-glutamyl cycle activity in a clonal pancreatic beta-cell line. Diabetologia 46:1512–1521